BAFF-R targeted monoclonal antibody (City of Hope)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBAFF-R targeted monoclonal antibody (City of Hope)
Drug Alias NameC-90 (City of Hope)TNFRSF13C targeted monoclonal antibody (City of Hope)BAFF-R CAR-T therapy (City of Hope/PeproMene Bio)C-55
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionB-cell activating factor receptor inhibitors
TargetsB-cell activating factor receptor
Therapy Area/IndicationsLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCity of Hope
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCity of Hope
Active IndicationsN/A
Inactive IndicationsLymphoma

Other Information

ATC CodeN/A
Related LinksN/A